Human Genome Epidemiology Literature Finder
|
Records 1 - 4 (of 4 Records) |
| Query Trace: Leukopenia and DPYD[original query] |
|---|
| Role of genetic and nongenetic factors for fluorouracil treatment-related severe toxicity: a prospective clinical trial by the German 5-FU Toxicity Study Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008 May 26 (13): 2131-8. Schwab Matthias, Zanger Ulrich M, Marx Claudia, Schaeffeler Elke, Klein Kathrin, Dippon Jürgen, Kerb Reinhold, Blievernicht Julia, Fischer Joachim, Hofmann Ute, Bokemeyer Carsten, Eichelbaum Michel, |
| The impact of ABCC11 polymorphisms on the risk of early-onset fluoropyrimidine toxicity. The pharmacogenomics journal 2016 Mar . Hamzic S, Wenger N, Froehlich T K, Joerger M, Aebi S, Largiadèr C R, Amstutz |
| Management of patients with reduced dihydropyrimidine dehydrogenase activity receiving combined 5-fluoruracil-/capecitabine-based chemoradiotherapy. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 2024 9 . E Hoffmann, A Toepell, A Peter, S Böke, C De-Colle, M Steinle, M Niyazi, C Ga |
| Influence of DPYD gene polymorphisms on 5-Fluorouracil toxicities in Thai colorectal cancer patients. Cancer chemotherapy and pharmacology 2024 12 95 (1): 2. Chalirmporn Atasilp, Natchaya Vanwong, Pavitchaya Yodwongjane, Phichai Chansriwong, Ekaphop Sirachainan, Thanyanan Reungwetwattana, Pimonpan Jinda, Somthawin Aiempradit, Suwannee Sirilerttrakul, Monpat Chamnanphon, Apichaya Puangpetch, Nipaporn Sankuntaw, Patompong Satapornpong, Thomas Fabienne, Chonlaphat Sukas |
- Page last reviewed:Feb 1, 2024
- Content source: